In other work, Zhang et al. [89] reported a bimodal biosensor for the detection of the EGFR L858R mutation, a key biomarker for specific non-small cell lung cancer (NSCLC) patients. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.